comparemela.com

Latest Breaking News On - Surrozen inc - Page 1 : comparemela.com

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the…

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Surrozen, Inc (NASDAQ:SRZNW) Sees Large Decrease in Short Interest

Surrozen, Inc. (NASDAQ:SRZNW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 11,800 shares, a decrease of 42.2% from the March 31st total of 20,400 shares. Based on an average daily trading volume, of 2,900 shares, the days-to-cover ratio […]

Surrozen, Inc (NASDAQ:SRZNW) Short Interest Down 42 2% in April

Surrozen, Inc. (NASDAQ:SRZNW – Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 11,800 shares, a decrease of 42.2% from the March 31st total of 20,400 shares. Based on an average trading volume of 2,900 shares, the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.